UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
This piece breaks down why Total Market Return 2024 matters, highlighting drivers, risks, and practical steps to align holdings with your goals.
28,491 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A little-known ETF with amplified crude exposure has jumped 289% year-to-date as oil holds near $80, highlighting the...
As markets digest a potential shift in leadership, the biggest test for any Fed chair may be broader than inflation. ...
A morning surge in AeroVironment stock popped today after reports of potential U.S. drone subsidies. This guide unpac...
When a long-time investor dumps a big stake, questions follow. This guide breaks down what an insider sale means for ...
A long standing trading rule is gone, and it could change how millions of small investors trade. This shift may lift ...
Rocket Lab has unveiled a bold $8 billion move by announcing a plan to acquire Iridium. This article breaks down what...
Baozun's baozun (bzun) 2025 earnings signal shifts in China’s DTC ecosystem. This article breaks down Q4 results, mar...
Choosing where to retire isn’t just about weather. It blends cost, healthcare access, taxes, and lifestyle. This guid...
Hearing aid costs top $7,000 for mid-range devices, and Original Medicare offers no coverage. The gap is reshaping se...
Nokia’s latest move isn't about handsets—it's about AI-friendly data-center networks. The Nokia acquired Infinera qui...
Inflation just 3-year high is reshaping everyday costs and the profit path for credit card lenders. This guide explai...